Chronic lymphocytic leukaemia (CLL) is characterised by the clonal expansion of mature CD19+CD23+CD5+ B-cells in the blood, bone marrow and lymphoid tissue [1]. Here, FCER2 is linked to B-cell chronic lymphocytic leukemia.